Met Life Investment Management, LLC Atara Biotherapeutics, Inc. Transaction History

Met Life Investment Management, LLC

  • $14.7 Billion
  • Q1 2024

Shares

46 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Apr 29, 2024
BUY
$1.5 - $3.04 $74,595 - $151,179
49,730 New
49,730 $80,000
Q1 2023

May 09, 2024
BUY
$2.8 - $5.46 $139,244 - $271,525
49,730 New
49,730 $144 Million
Q1 2023

May 15, 2023
BUY
$2.8 - $5.46 $38,239 - $74,567
13,657 Added 37.86%
49,730 $144,000
Q4 2022

May 10, 2024
SELL
$2.85 - $5.18 $31,968 - $58,104
-11,217 Reduced 23.72%
36,073 $118,000
Q4 2022

Jun 14, 2023
SELL
$2.85 - $5.18 $38,922 - $70,743
-13,657 Reduced 27.46%
36,073 $118,000
Q4 2022

Mar 22, 2023
SELL
$2.85 - $5.18 $31,968 - $58,104
-11,217 Reduced 23.72%
36,073 $118,000
Q4 2022

Feb 15, 2023
SELL
$2.85 - $5.18 $31,968 - $58,104
-11,217 Reduced 23.72%
36,073 $118,000
Q3 2022

May 10, 2024
BUY
$2.85 - $8.73 $14,774 - $45,256
5,184 Added 12.31%
47,290 $178,000
Q3 2022

Jun 14, 2023
SELL
$2.85 - $8.73 $6,954 - $21,301
-2,440 Reduced 4.91%
47,290 $178,000
Q3 2022

Mar 22, 2023
BUY
$2.85 - $8.73 $14,774 - $45,256
5,184 Added 12.31%
47,290 $178,000
Q3 2022

Nov 14, 2022
BUY
$2.85 - $8.73 $14,774 - $45,256
5,184 Added 12.31%
47,290 $179,000
Q2 2022

May 10, 2024
SELL
$4.69 - $9.84 $21,466 - $45,037
-4,577 Reduced 9.8%
42,106 $328,000
Q2 2022

Jun 20, 2023
SELL
$4.69 - $9.84 $35,756 - $75,020
-7,624 Reduced 15.33%
42,106 $328,000
Q2 2022

Mar 22, 2023
SELL
$4.69 - $9.84 $21,466 - $45,037
-4,577 Reduced 9.8%
42,106 $328,000
Q2 2022

Aug 11, 2022
SELL
$4.69 - $9.84 $21,466 - $45,037
-4,577 Reduced 9.8%
42,106 $328,000
Q1 2022

May 10, 2024
BUY
$8.44 - $16.89 $394,004 - $788,475
46,683 New
46,683 $433,000
Q1 2022

Jun 20, 2023
SELL
$8.44 - $16.89 $25,716 - $51,463
-3,047 Reduced 6.13%
46,683 $433,000
Q1 2022

Mar 22, 2023
BUY
$8.44 - $16.89 $142,889 - $285,947
16,930 Added 56.9%
46,683 $433,000
Q1 2022

May 12, 2022
BUY
$8.44 - $16.89 $142,889 - $285,947
16,930 Added 56.9%
46,683 $434,000
Q4 2021

Jun 21, 2023
SELL
$14.7 - $19.89 $293,661 - $397,342
-19,977 Reduced 40.17%
29,753 $468,000
Q3 2021

Jun 21, 2023
SELL
$11.99 - $17.9 $239,524 - $357,588
-19,977 Reduced 40.17%
29,753 $532,000
Q2 2021

Jun 21, 2023
SELL
$12.89 - $16.58 $257,503 - $331,218
-19,977 Reduced 40.17%
29,753 $462,000
Q1 2021

May 17, 2024
BUY
$14.0 - $20.72 $416,542 - $616,482
29,753 New
29,753 $427,000
Q1 2021

Jun 26, 2023
SELL
$14.0 - $20.72 $279,678 - $413,923
-19,977 Reduced 40.17%
29,753 $427 Million
Q4 2020

Jun 22, 2023
SELL
$12.67 - $26.23 $253,108 - $523,996
-19,977 Reduced 40.17%
29,753 $584,000
Q3 2020

Jun 26, 2023
SELL
$11.92 - $15.87 $238,125 - $317,034
-19,977 Reduced 40.17%
29,753 $385,000
Q2 2020

May 24, 2024
BUY
$7.53 - $14.93 $224,040 - $444,212
29,753 New
29,753 $434 Million
Q2 2020

Jun 26, 2023
SELL
$7.53 - $14.93 $150,426 - $298,256
-19,977 Reduced 40.17%
29,753 $433,000
Q2 2020

Mar 22, 2023
BUY
$7.53 - $14.93 $45,036 - $89,296
5,981 Added 25.16%
29,753 $433,000
Q2 2020

Aug 14, 2020
BUY
$7.53 - $14.93 $45,036 - $89,296
5,981 Added 25.16%
29,753 $434,000
Q1 2020

Jul 12, 2023
SELL
$5.69 - $17.78 $147,701 - $461,533
-25,958 Reduced 52.2%
23,772 $202,000
Q4 2019

Jul 12, 2023
SELL
$10.89 - $16.79 $282,682 - $435,834
-25,958 Reduced 52.2%
23,772 $391,000
Q3 2019

Jul 12, 2023
SELL
$12.03 - $19.94 $312,274 - $517,602
-25,958 Reduced 52.2%
23,772 $335,000
Q3 2019

Mar 22, 2023
BUY
$12.03 - $19.94 $59,368 - $98,403
4,935 Added 26.2%
23,772 $335,000
Q3 2019

Nov 14, 2019
BUY
$12.03 - $19.94 $59,368 - $98,403
4,935 Added 26.2%
23,772 $336,000
Q2 2019

Jul 12, 2023
SELL
$19.05 - $41.04 $588,511 - $1.27 Million
-30,893 Reduced 62.12%
18,837 $378,000
Q1 2019

Jul 13, 2023
SELL
$28.4 - $41.74 $877,361 - $1.29 Million
-30,893 Reduced 62.12%
18,837 $748,000
Q4 2018

Jul 13, 2023
SELL
$30.9 - $42.97 $954,593 - $1.33 Million
-30,893 Reduced 62.12%
18,837 $654,000
Q4 2018

Mar 22, 2023
SELL
$30.9 - $42.97 $321,051 - $446,458
-10,390 Reduced 35.55%
18,837 $654,000
Q4 2018

Feb 14, 2019
SELL
$30.9 - $42.97 $321,051 - $446,458
-10,390 Reduced 35.55%
18,837 $654,000
Q3 2018

Jul 13, 2023
SELL
$35.05 - $43.5 $1.08 Million - $1.34 Million
-30,893 Reduced 62.12%
18,837 $778,000
Q3 2018

Mar 22, 2023
SELL
$35.05 - $43.5 $239,952 - $297,801
-6,846 Reduced 18.98%
29,227 $1.21 Million
Q3 2018

Nov 14, 2018
BUY
$35.05 - $43.5 $364,169 - $451,965
10,390 Added 55.16%
29,227 $1.21 Million
Q2 2018

Aug 15, 2018
BUY
$35.15 - $51.45 $132,902 - $194,532
3,781 Added 25.11%
18,837 $692,000
Q1 2018

May 15, 2018
BUY
$18.0 - $48.35 $55,674 - $149,546
3,093 Added 25.85%
15,056 $587,000
Q4 2017

Feb 15, 2018
BUY
$13.2 - $18.1 $157,911 - $216,530
11,963
11,963 $217,000

Others Institutions Holding ATRA

# of Institutions
87
Shares Held
85M
Call Options Held
18.4K
Put Options Held
51.3K
View Full List

About Atara Biotherapeutics, Inc.

ATRA Quotes by TradingView
  • Ticker ATRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,362,304
  • Market Cap $728M
  • Description
  • Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...
More about ATRA
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email